ArticlePloS one2019

CRISPR-Cas9 mediated CD133 knockout inhibits colon cancer invasion through reduced epithelial-mesenchymal transition.

Wanlu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.